Abstract:Background & Aims Macrophages display remarkable plasticity and can interact with surrounding cells to affect hepatic immunity and tissue remodelling during the progression of liver diseases. Peroxisome proliferator-activated receptor gamma (PPAR gamma) plays a critical role in macrophage maturation, polarization and metabolism. In this study, we investigated the role of PPAR gamma in macrophage-hepatic stellate cell (HSC) interaction during non-alcoholic steatohepatitis (NASH) development. Methods Wild-type, Pparg(fl/fl) and Pparg(Delta Lyz2) mice were fed a methionine- and choline-deficient (MCD) diet to induce NASH. Depletion of macrophages was performed using an injection of gadolinium chloride intraperitoneally. PPAR gamma-overexpressing or PPAR gamma-knockout macrophages were stimulated with saturated fatty acid (SFA) and cocultured with HSCs in a conditioned medium or the transwell coculture system. Results Depletion of macrophages inhibited HSC activation and ameliorated NASH progression in MCD diet-fed mice. Coculturing HSCs with macrophages or culturing HSCs in a macrophage-conditioned medium-facilitated HSC activation, and this effect was magnified when macrophages were metabolically activated by SFA. Moreover, the absence of PPAR gamma in macrophages enhanced metabolic activation, promoting the migration and activation of HSCs through IL-1 beta and CCL2. In contrast, overexpression of PPAR gamma in macrophages obtained the opposite effects. In vivo, macrophage-specific PPAR gamma knockout affected the phenotype of hepatic macrophages and HSCs, involving the MAPK and NLRP3/caspase-1/IL-1 beta signalling pathways. Infiltrating hepatic monocyte-derived macrophages became the predominant macrophages in NASH liver, especially in Pparg(Delta Lyz2) mice, paralleling with aggravated inflammation and fibrosis. Conclusions Regulating macrophage PPAR gamma affected the metabolic activation of macrophages and their interaction with HSCs. Macrophage-specific PPAR gamma may be an attractive therapeutic target for protecting against NASH-associated inflammation and fibrosis.

Transmembrane and coiled-coil domain family 3 gene is a novel target of hepatic peroxisome proliferator-activated receptor γ in fatty liver disease

Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor α agonists

MiR-103-3p Promotes Hepatic Steatosis to Aggravate Nonalcoholic Fatty Liver Disease by Targeting of ACOX1

FAM3A is a target gene of peroxisome proliferator-activated receptor gamma.

CBFA2T3 Is PPARA Sensitive and Attenuates Fasting-Induced Lipid Accumulation in Mouse Liver

Hepatocyte-secreted FAM3D Ameliorates Hepatic Steatosis by Activating FPR1-hnRNP U-GR-SCAD Pathway to Enhance Lipid Oxidation

FAM3 Gene Family: A Promising Therapeutical Target for NAFLD and Type 2 Diabetes.

FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis.

PIK3R3 Regulates PPARα Expression to Stimulate Fatty Acid Β-Oxidation and Decrease Hepatosteatosis

Fatty liver is associated with impaired activity of PPARγ-coactivator 1α (PGC1α) and mitochondrial biogenesis in mice

Regulation of the Macrophage-Hepatic Stellate Cell Interaction by Targeting Macrophage Peroxisome Proliferator-Activated Receptor Gamma to Prevent Non-Alcoholic Steatohepatitis Progression in Mice

The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fats

Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis.

Pik3r3 Regulates Ppar Alpha Expression To Stimulate Fatty Acid Beta-Oxidation And Decrease Hepatosteatosis

LAMP3 Regulates Hepatic Lipid Metabolism Through Activating PI3K/Akt Pathway

Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor delta from Peroxisome proliferator-activated receptor gamma in the ob/ob mouse

Ccdc3: A New P63 Target Involved in Regulation of Liver Lipid Metabolism.

PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice

LAMP3 regulates hepatic lipid metabolism through activating PI3K/Akt pathway.

PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice

The Expression and CpG Island Methylation of PNPLA3 in Experimental Nonalcoholic Fatty Liver Disease